BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24706591)

  • 1. The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency.
    Tahmasebi S; Ghorbani M; Savage P; Gocevski G; Yang XJ
    Stem Cells; 2014 Apr; 32(4):1012-20. PubMed ID: 24706591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.
    He X; Lai Q; Chen C; Li N; Sun F; Huang W; Zhang S; Yu Q; Yang P; Xiong F; Chen Z; Gong Q; Ren B; Weng J; Eizirik DL; Zhou Z; Wang CY
    Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
    Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A
    Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
    Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
    Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA; Lima CD
    Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
    Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
    J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency.
    López I; Chalatsi E; Ellenbroek SIJ; Andrieux A; Roux PF; Cerapio JP; Jouvion G; van Rheenen J; Seeler JS; Dejean A
    Oncogene; 2020 Oct; 39(43):6692-6703. PubMed ID: 32948837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition.
    Li S; Xiao F; Zhang J; Sun X; Wang H; Zeng Y; Hu J; Tang F; Gu J; Zhao Y; Jin Y; Liao B
    Stem Cell Reports; 2018 Oct; 11(4):973-987. PubMed ID: 30269953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
    Subramaniam S; Mealer RG; Sixt KM; Barrow RK; Usiello A; Snyder SH
    J Biol Chem; 2010 Jul; 285(27):20428-32. PubMed ID: 20424159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Transthyretin a Regulator of Ubc9 SUMOylation?
    Wieczorek E; Kędracka-Krok S; Sołtys K; Jankowska U; Hołubowicz R; Seliga J; Ożyhar A
    PLoS One; 2016; 11(8):e0160536. PubMed ID: 27501389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells.
    Yukita A; Hosoya A; Ito Y; Katagiri T; Asashima M; Nakamura H
    Bone; 2012 May; 50(5):1092-9. PubMed ID: 22366399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
    J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBC9 regulates cardiac sodium channel Na
    Tang B; Hu Y; Wang Z; Cheng C; Wang P; Liang L; Xiong H; Luo C; Xu C; Chen Q; Wang QK
    J Mol Cell Cardiol; 2019 Apr; 129():79-91. PubMed ID: 30772377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between
    Yi J; Wang Y; Li Q; Zhang H; Shao Z; Deng X; He J; Xiao C; Wang Z; Wang Y; Chen C
    J Vet Sci; 2019 Sep; 20(5):e54. PubMed ID: 31565897
    [No Abstract]   [Full Text] [Related]  

  • 15. Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.
    Gupta MK; Gulick J; Liu R; Wang X; Molkentin JD; Robbins J
    Circ Res; 2014 Sep; 115(8):721-9. PubMed ID: 25097219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pcgf6, a polycomb group protein, regulates mesodermal lineage differentiation in murine ESCs and functions in iPS reprogramming.
    Zdzieblo D; Li X; Lin Q; Zenke M; Illich DJ; Becker M; Müller AM
    Stem Cells; 2014 Dec; 32(12):3112-25. PubMed ID: 25187489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective culture conditions for the induction of pluripotent stem cells.
    Okada M; Oka M; Yoneda Y
    Biochim Biophys Acta; 2010 Sep; 1800(9):956-63. PubMed ID: 20417254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
    Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
    Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.